Recent News

• 03.11.2026 - CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering
• 03.10.2026 - CRISPR Therapeutics Announces Proposed Convertible Senior Notes Offering
• 02.12.2026 - CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
• 01.12.2026 - CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2026 Milestones

Recent Filings

• 03.11.2026 - 8-K Current report
• 03.11.2026 - EX-99.1 EX-99.1
• 02.20.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.20.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.17.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.12.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.12.2026 - EX-99.1 EX-99.1
• 02.12.2026 - 8-K Current report
• 02.05.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.27.2026 - 4 Statement of changes in beneficial ownership of securities